Newsletter

News of Kasznar Leonardos Intelectual Property, with Offices in RJ, SP and RS – Brazil.

Brazilian National Health Surveillance Agency (ANVISA) decides not to comment on a bill that proposes changes to the Industrial Property Act

he  Last Tuesday (February 9th, 2021), the Board of the National Health Surveillance Agency (ANVISA) decided not to comment on the Senate Brazilian National Health Surveillance Agency (ANVISA) decides not to comment on a bill that proposes changes to the Industrial Property Act

BPTO publishes Manual on Geographical Indications

The Brazilian Patent and Trademark Office (BPTO) published on Tuesday, January 5th 2021, the first edition of the Manual of Geographical Indications. BPTO publishes Manual on Geographical Indications

BPTO publishes phase II of the Patent Prosecution Highway (PPH) Program

The Brazilian Patent and Trademark Office (BPTO) published, by means of Ordinance n° 404, dated December 21, 2020, phase II of the BPTO publishes phase II of the Patent Prosecution Highway (PPH) Program

New Guidelines for Examination of Patent Applications for Computer-Implemented Inventions

Four years after the publication of the first Examination Guidelines for computer-implemented inventions, the Brazilian Patent Office published a new revised version New Guidelines for Examination of Patent Applications for Computer-Implemented Inventions

Brazilian Data Protection Office’s website is on

Although it was created in July 2019, the Brazilian Data Protection Office (ANPD) has started to show its operationalization. Two months after Brazilian Data Protection Office’s website is on

UN removes Cannabis from List of Narcotic Substances

On December 2, 2020, through its Commission on Narcotics, the United Nations approved a recommendation issued by WHO – World Health Organization UN removes Cannabis from List of Narcotic Substances

Revised Guidelines for the Examination of Patent Applications in the Biotechnology field in force

The Revised Guidelines for the Examination of Patent Applications in the Biotechnology Field (Normative Instruction INPI/PR n° 118/2020) finally entered into force Revised Guidelines for the Examination of Patent Applications in the Biotechnology field in force

ANVISA published manuals related to prior consent of patent applications

The Brazilian FDA (ANVISA) published on November 19, 2020, four manuals regarding the analysis of prior consent of patent applications related to ANVISA published manuals related to prior consent of patent applications

ANVISA decides that a patent application related to pharmaceutical use of cannabinoids is not to be deemed as against public health

On November 17th, 2020, ANVISA’s Board of Directors (BoD) unanimously granted an administrative appeal for reassessment of prior consent of a patent ANVISA decides that a patent application related to pharmaceutical use of cannabinoids is not to be deemed as against public health

The controversy regarding amendments to patent applications in Brazil – A new chapter begins

As reported in our Newsletter #06, sent in March 2019, the Public Civil Action filed in 2002 by the Federal Public Prosecution The controversy regarding amendments to patent applications in Brazil – A new chapter begins